Intellectual Property Intellectual Property

Curb your (lobbying) enthusiasm? Navigating Canada’s lobbying regulations – insights for the pharmaceutical industry

The interplay of legal frameworks, ethical considerations and diverse stakeholders make lobbying a complex and sensitive process.

Winning wellness: strategic IP and regulatory considerations in Canada’s booming natural health products industry

Canadian natural health products have surged to an industry worth more than $13 billion in recent years. A strategic approach to intellectual...

U.K. appellate court rules artificial neural network application is not patent-eligible subject matter

Although artificial neural networks (ANNs) have evolved to increasingly form the backbone of modern commerce, their patentability remained...

Québec publishes final regulation modifying the Regulation respecting the language of commerce and business

In January 2024, the Québec government proposed extensive amendments to the Regulation respecting the language of commerce and...

Canadian Intellectual Property Office (CIPO) increasing official fees effective January 1, 2024

CIPO is set to substantially increase official fees for patents, trademarks, industrial designs and copyrights on January 1, 2024.

ISED’s Voluntary Code of Conduct on the Responsible Development and Management of Advanced Generative AI Systems

The federal government has announced a voluntary code of conduct intended to commit creators of advanced generative systems to take steps to identify...

Overbroad patent claims: Canadian law may draw strength from policy behind U.S. and U.K. Supreme Court rulings

A recent U.S. Supreme Court decision serves as a reminder that a bargain underlies the issuance of a patent and that an applicant must fully and...

Osler AI Series: Data, Intellectual Property and Privacy

Our second webinar focuses on data, intellectual property and privacy.

PMPRB releases long-awaited draft guidelines regarding excessive drug pricing under new regime

The Patented Medicine Prices Review Board (PMPRB) has updated its approach to excessive pricing. Osler’s Nathaniel Lipkus and Yael Mansour discuss...